Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Mabthera Rituximab 10mg/mL Concentrate for infusion Roche Products (NZ) Limited F Hoffmann-La Roche Limited, Basel, Switzerland Genentech Inc, California, United States of America Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, Oregon, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Ristova Rituximab 10mg/mL Concentrate for infusion Roche Products (NZ) Limited F Hoffmann-La Roche Limited, Basel, Switzerland Genentech Inc, California, United States of America Roche Diagnostics GmbH, Mannheim, Germany Genentech Inc, Oregon, United States of America
|
Dated this 16th day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).